TCL Archive Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer March 26, 2010
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005